These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 14753658

  • 1. Neuroimaging in amyotrophic lateral sclerosis.
    Kalra S, Arnold D.
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Dec; 4(4):243-8. PubMed ID: 14753658
    [Abstract] [Full Text] [Related]

  • 2. Amyotrophic lateral sclerosis and primary lateral sclerosis: The role of diffusion tensor imaging and other advanced MR-based techniques as objective upper motor neuron markers.
    Wang S, Melhem ER.
    Ann N Y Acad Sci; 2005 Dec; 1064():61-77. PubMed ID: 16394148
    [Abstract] [Full Text] [Related]

  • 3. [Objective markers for upper motor neuron involvement in amyotrophic lateral sclerosis].
    Iwata NK.
    Brain Nerve; 2007 Oct; 59(10):1053-64. PubMed ID: 17969345
    [Abstract] [Full Text] [Related]

  • 4. Magnetic resonance imaging and magnetic resonance spectroscopy in a patient with amyotrophic lateral sclerosis and frontotemporal dementia.
    Sarac H, Zagar M, Vranjes D, Henigsberg N, Bilić E, Pavlisa G.
    Coll Antropol; 2008 Jan; 32 Suppl 1():205-10. PubMed ID: 18405084
    [Abstract] [Full Text] [Related]

  • 5. Amyotrophic lateral sclerosis with predominant pyramidal signs -- early diagnosis by magnetic resonance imaging.
    Pradhan S, Yadav R, Mishra VN, Aurangabadkar K, Sawlani V.
    Magn Reson Imaging; 2006 Feb; 24(2):173-9. PubMed ID: 16455406
    [Abstract] [Full Text] [Related]

  • 6. MRI-based functional neuroimaging in ALS: an update.
    Lulé D, Ludolph AC, Kassubek J.
    Amyotroph Lateral Scler; 2009 Feb; 10(5-6):258-68. PubMed ID: 19922112
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Amyotrophic lateral sclerosis associated with pregnancy.
    Tyagi A, Sweeney BJ, Connolly S.
    Neurol India; 2001 Dec; 49(4):413-4. PubMed ID: 11799421
    [Abstract] [Full Text] [Related]

  • 10. [Amyotrophic lateral sclerosis: differential diagnosis and frontier forms].
    Magistris MR.
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S67-4S80. PubMed ID: 17128092
    [Abstract] [Full Text] [Related]

  • 11. Transcallosal inhibition in amyotrophic lateral sclerosis.
    Wittstock M, Wolters A, Benecke R.
    Clin Neurophysiol; 2007 Feb; 118(2):301-7. PubMed ID: 17140846
    [Abstract] [Full Text] [Related]

  • 12. Cortical activation during motor imagery is reduced in Amyotrophic Lateral Sclerosis.
    Stanton BR, Williams VC, Leigh PN, Williams SC, Blain CR, Giampietro VP, Simmons A.
    Brain Res; 2007 Oct 03; 1172():145-51. PubMed ID: 17765211
    [Abstract] [Full Text] [Related]

  • 13. Cortical excitability testing distinguishes Kennedy's disease from amyotrophic lateral sclerosis.
    Vucic S, Kiernan MC.
    Clin Neurophysiol; 2008 May 03; 119(5):1088-96. PubMed ID: 18313980
    [Abstract] [Full Text] [Related]

  • 14. MRI in amyotrophic lateral sclerosis: hyperintensity of the corticospinal tract.
    Kriaa S, Zbidi M, Hafsa C, Golli M, Gannouni A.
    Neurol Clin Neurophysiol; 2005 Dec 20; 2005():3. PubMed ID: 17139392
    [Abstract] [Full Text] [Related]

  • 15. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS.
    Mitsumoto H, Ulug AM, Pullman SL, Gooch CL, Chan S, Tang MX, Mao X, Hays AP, Floyd AG, Battista V, Montes J, Hayes S, Dashnaw S, Kaufmann P, Gordon PH, Hirsch J, Levin B, Rowland LP, Shungu DC.
    Neurology; 2007 Apr 24; 68(17):1402-10. PubMed ID: 17452585
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of corticospinal tracts in ALS with diffusion tensor MRI and brainstem stimulation.
    Iwata NK, Aoki S, Okabe S, Arai N, Terao Y, Kwak S, Abe O, Kanazawa I, Tsuji S, Ugawa Y.
    Neurology; 2008 Feb 12; 70(7):528-32. PubMed ID: 18268244
    [Abstract] [Full Text] [Related]

  • 17. Neuropsychiatric systemic lupus erythematosus presenting as amyotrophic lateral sclerosis.
    Maldonado ME, Williams RC, Adair JC, Hart BL, Gregg L, Sibbitt WL.
    J Rheumatol; 2002 Mar 12; 29(3):633-5. PubMed ID: 11908583
    [Abstract] [Full Text] [Related]

  • 18. Is magnetic resonance imaging a plausible biomarker for upper motor neuron degeneration in amyotrophic lateral sclerosis/primary lateral sclerosis or merely a useful paraclinical tool to exclude mimic syndromes? A critical review of imaging applicability in clinical routine.
    Rocha AJ, Maia Júnior AC.
    Arq Neuropsiquiatr; 2012 Jul 12; 70(7):532-9. PubMed ID: 22836461
    [Abstract] [Full Text] [Related]

  • 19. [Classical and atypical clinical features in amyotrophic lateral sclerosis].
    Pradat PF, Bruneteau G.
    Rev Neurol (Paris); 2006 Jun 12; 162 Spec No 2():4S17-4S24. PubMed ID: 17128085
    [Abstract] [Full Text] [Related]

  • 20. Subcortical motor plasticity in patients with sporadic ALS: An fMRI study.
    Tessitore A, Esposito F, Monsurrò MR, Graziano S, Panza D, Russo A, Migliaccio R, Conforti FL, Morrone R, Quattrone A, Di Salle F, Tedeschi G.
    Brain Res Bull; 2006 May 15; 69(5):489-94. PubMed ID: 16647577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.